FDA Inspection
David S. Siegel, M.D.David S. Siegel, M.D. – FDA Inspection, Jan 27, 2012
Record Details
This FDA Inspection record concerns David S. Siegel, M.D., with an inspection on January 27, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- David S. Siegel, M.D.
- Inspection Date
- January 27, 2012
- Product Type
- Drugs
View Company Profile
ID · e50b3dd6-bb93-43b3-a624-9f39fd27a1bd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 767213
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of David S. Siegel, M.D.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 2, 2020 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| September 18, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 25, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for David S. Siegel, M.D.
- FDA Inspection 1133295 - 2020-11-02
- FDA Inspection 944842 - 2015-09-18
- FDA Inspection 791988 - 2012-07-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.